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1. INTRODUCTION 
Teleocidin and its derivative dihydroteleocidin 
are toxic substances isolated from Streptomyces [ 11. 
They induce ornithine decarboxylase activity when 
painted on the skin, cause adhesion of human pro- 
myelocytic leukemia cells, inhibit terminal differ- 
entiation of Friend erythroleukemia cells, and 
exert mitogenic effects in cultured human lympho- 
cytes [2-41. In addition, dihydroteleocidin shows 
potent tumor-promoting activity when applied on 
mouse skin [4]. The effects of teleocidins are essen- 
tially identical to those produced by 12-0-tetrade- 
canoyl-phorbol-13-acetate (TPA), a phorbol ester 
whose initial site of action is the cell membrane. 
Furthermore, teleocidins have been shown to 
interact directly with the receptor for phorbol esters 
[S], and as TPA [5-71, to inhibit the binding of 
epidermal growth factor (EGF) to its receptor [5]. 
Because TPA acts synergistically with most growth 
factors, it may increase non-selectively cellular 
sensitivity to any growth factor, or, act through a 
specific hormonal pathway [6-91; one such path- 
way may be in certain cell types, that utilized by 
vasopressin [8]. 
toma cells. Provided the lysosomal inhibitor chlo- 
roquine is present, teleocidin inhibits the internali- 
zation and the nuclear association of EGF. These 
results appear to be of interest for understanding 
the mechanism of action of both EGF and teleoci- 
din. 
2. MATERIALS AND METHODS 
Human HUH hepatoma cells were kindly sup- 
plied by Dr J. Sato (Okayama Univ.) and Dr K. 
Takeda (Kagawa Univ.). Teleocidin was obtained 
from Fujisawa Pharmaceutical Industries (Osaka). 
TPA and retinoic acid were purchased from Sigma 
(St Louis MO). EGF was purified by Savage’s me- 
thod [ 131. HUH cells (1 x 105) were seeded into a 
well of culture plate (Linbro, 24 wells/plate) con- 
taining 1 ml of RPM1 1640 containing 10% fetal calf 
serum. Incubations were in a humidified atmos- 
phere containing 5% CO2. When effects of EGF 
were examined, a low serum medium (RPM1 1640 
containing 0.5% fetal calf serum) was employed. 
In AH66 rat hepatoma cells cultured in a low 
serum medium, teleocidin and TPA stimulate mito- 
genesis, antagonize EGF-induced mitogenesis 
and inhibit in a transient manner the binding of 
EGF to its receptors [IO- 121. Retinoic acid, a sub- 
stance which inhibits the induction of ornithine de- 
carboxylase by TPA and teleocidin in mouse skin 
[2], also acted antagonistically to teleocidin with 
regard to mitogenesis and EGF binding in hepa- 
toma cells. Here the effects of teleocidin, TPA and 
retinoic acid on mitogenesis and EGF binding have 
been characterized further in human HUH hepa- 
Cell proliferation was assessed from cell counts 
from l-6 days following addition of teleocidin and 
other drugs to the culture medium. Cells were 
counted with a hemocytometer after dissociation of 
the monolayers in phosphate-buffered saline con- 
taining 0.1% EDTA. 
Protein synthesis was measured using [3H]leucine 
as a precursor [ 121. HUH cells (5 x lo5 cells) were 
grown for 24 h in 2 ml culture medium containing 
10% fetal calf serum and, when indicated, teleocidin 
(50 ng/ml). [3H]Leucine (1 pCi/ml; New England 
Nuclear, 51 Ci/mmol) was added, and incubation 
was continued for an additional 6 h. [3H]Leucine 
incorporation into trichloroacetic acid-precipitable 
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material of cell lysates was measured as in [ 121. 
Results were expressed as mean f SD (3 determin- 
ations). 
Cell surface binding, internalization and nuclear 
association of EGF were assessed using ‘251-labeled 
EGF as in li and in the presence of chloroquine as 
in [ 14-171. a 51-EGF was prepared by the chlor- 
amine T method with spec. act. lo6 cpm/ng [16]. 
HUH cells (lO’/well) were grown for 3 days in 1 ml 
RPM1 1640 containing 10% fetal calf serum. The 
medium was then replaced by fresh medium con- 
taing ‘251-EGF (lo5 cpm), chloroquine (100 PM) 
and, when indicated, teleocidin or other drugs. 
After 3-18 h incubation at 37°C cells were wash- 
ed 3 times with ice-cold phosphate-buffered saline. 
Surface-bound and internalized 1251-EGF were 
measured as in [17]. Cell monolayers were treated 
with 1 ml 0.2 M acetic acid (pH 2.5) containing 0.5 M 
NaCl for 6 min at 4°C. This solution was re- 
moved by aspiration, and the cells remaining in 
the culture wells were solubilized in 2 N NaOH. 
The acid-extracted radioactivity was assumed to re- 
present surface-bound ‘251-EGF, and the NaOH- 
solubilized radioactivity, internalized EGF [ 171. 
Nuclear accumulation of ‘251-EGF was measured 
as in [ 14,151. Cells washed as above were lysed in 2 
ml phosphate-buffered saline containing 0.5% NP 
40; the lysates were then centrifuged through a 0.88 
M sucrose cushion as in [ 14,151. Since treatment by 
teleocidin and other drugs caused a decrease in the 
number of cells (lo-20% after 24 h), all binding 
data were expressed as cpm/5 x lo5 cells. Appro- 
priate corrections were made for the non-specific 
association of the radioactivity to cells by perform- 
ing parallel incubations in the presence of excess 
(5 pg/ml) native EGF. 
3. RESULTS 
The effects of teleocidin, TPA and retinoic acid 
on the proliferation of HUH hepatoma cells as a 
function of time and drug concentration are shown 
in tig.1. Teleocidin (10 ng/ml) inhibited the proli- 
feration of cells in response to both fetal calf serum 
(10%) and EGF (50 ng/ml) in low-serum medium. 
TPA (10 ng/ml) and retinoic acid (2 pg/ml) also 
inhibited cell proliferation induced by 10% fetal calf 
serum. The effects of teleocidin and retinoic acid on 
cell proliferation were additive. The effect of teleo- 
cidin in the presence or absence of retinoic acid was 
6 
detectable at 0.1 ng/ml and maximal at 100 ng/ml. 
To assess whether the effects of teleocidin on cell 
proliferation were related to its toxicity, protein 
s nthesis 
[ 1 
was studied. The incorporation of 
Hlleucine by cells grown in the presence of teleo- 
cidin (12, 229 2 447 cpm/ lo6 cells) was virtually 
indistinguishable from that by untreated cells 
(11 690 + 933 cpm/ lo6 cells). Thus, teleocidin does 
not appear to interfere with protein synthesis. 
Teleocidin and TPA, but not retinoic acid, redu- 
ced the amount of surface-bound ‘251-EGF. How- 
ever, this was a transient phenomenon which oc- 
curred only during the first 3 h; after 6 h, little 
change in surface-bound EGF was observed (tig.2). 
In contrast, teleocidin and TPA caused a marked 
and sustained decrease in the amount of internal- 
ized EGF (fig.3). These inhibitory effects of teleo- 
cidin were observed irrespective of the presence of 
retinoic acid (Iig.2,3). The effect of teleocidin on 
EGF internalization was dependent on the concen- 
tration of drug; it was half-maximal at 0.3 ng/ml 
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Fig.1. Inhibition of cell proliferation by teleocidin. (a) 
Time course: 1 x lo5 of HUH cells were cultured in 1 ml 
RPM1 1640 medium containing 10% or 0.5% fetal bovine 
serum. Reagents were added at the start of culture: 
(A-A) serum 10%; (A-A) serum 10% + teleocidin 10 
ng/ml; (O-II) serum 0.5% + EGF 50 ng/ml; (0-e) 
serum 0.5% + EGF 50ng/ml + teleocidin 10 ng/ml; 
(0-n) serum 10% + retinoic acid 2 pg/ml; (m-m) 
serum 10% + retinoic acid 2 pg/ml + teleocidin 10 
ng/ml; (X-X) serum 0.5%; (+-_*) serum 10% + TPA 
10 ng/ml. (b) Dose response: 1 x lo5 of HUH cells were 
cultured for 5 days in RPM1 1640 medium + 10% fetal 
bovine serum. Teleocidin and retinoic acid were added at 
the start of culture: (O-O) teleocidin (O-100 ng/ml); 
(0-0) teleocidin (O-100 ng/ml) + retinoic acid (2 
pg/ml); ordinate, cell no. x 10-5/well. 
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Fig.2. Effect of teleocidin on EGF binding. (a) Time 
course: HUH cells were incubated with t251-EGF 
(100 000 cpm/well) and chloroquine (100 PM). Teleoci- 
din (10 @ml), TPA (10 ng/ml) and/or retinoic acid (2 
pg/ml) were added and after various incubation periods 
at 37°C the amount of surface-bound t251-EGF was 
measured; (O-O) retinoic acid; (m--m) retinoic acid + 
teleocidin; (O-O) none; (o-0) teleocidin; (A-A) 
TPA. (b) Dose response: HUH cells were incubated with 
t251-EGF (100 000 cpm/well) and chloroquine (100 PM) 
in the presence (O-O) or absence (O-O) of retinoic 
acid (2 pg/ml). Different concentrations of teleocidin 
were added (abscissa) and incubated for 18 h at 37°C; 
ordinate, surface-bound 1251-EGF (cpm x 10W3)/ 
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Fig.3. Effect of teleocidin on the internalization .^_ .__ 
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lLJI-EGF. HUH cells were incubated with tL’I-EGF 
(100 000 cpm/well) and chloroquine (100 PM) under the 
simultaneous presence of teleocidin, TPA and/or retinoic 
acid. The amounts of internalized 1251-EGF (ordinate, 
cpm/S x lo5 cells) were measured as in section 2. (a) 
Time course: (o-0) retinoic acid 2 pgg/ml; (m-m) reti- 
noic acid 2 pg/ml + teleocidin 10 ng/ml; (O-O) none; 
(0-a) teleocidin 10 ng/ml; (A-A) TPA 10 ng/ml. (b) 
Dose response: cells were incubated for 18 h at 37°C with 
different concentrations of teleocidin; (O-O) none: 
(o-0) retinoic acid 2 pg/ml. 
(a) 
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Fig.4. Effect of teleocidin on the nuclear accumulation of 
t251-EGF. HUH cells were incubated with t251-EGF 
(100 000 cpm/well) in the presence or absence of various 
reagents, and the amount of EGF in NP40-extracted cell 
remnants was measured: ordinate, cpm/5 x lo5 cells. (a) 
Time course: (O-O) chloroquine 100 PM; (e-0) 
chloroquine 100 PM + teleocidin 10 ng/ml; (0-0) 
chloroquine 100 PM + retinoic acid 2 pg/ml; (m-m) 
chloroquine 100 IJM + retinoic acid 2 pg/ml + teleocidin 
10 ng/ml; (A-A) chloroquine 100 PM + TPA 10 ng/ml; 
(x-x) medium only. (b) Dose response: cells were in- 
cubated for 24 h with various concentrations of teleocidin 
(abscissa). Chloroquine and/or retinoic acid were added 
simultaneously with teleocidin: (O-O) chloroquine 100 
PM; (o-0) chloroquine 100 PM + retinoic acid 2 
pglml; (0-0) chloroquine 50 PM; (A-A) chloroquine 
100 PM; (x-x) medium only. 
and virtually maximal at 10 ng/ml. At all concen- 
trations of teleocidin tested, the amount of surface- 
bound and internalized EGF was slightly greater 
in the presence of retinoic acid than in its absence 
(@.2b,3b). Fig.4 demonstrates that the nuclear 
accumulation of ‘251-EGF also decreased in teleo- 
cidin- and TPA-treated cells. This inhibitory effect 
was maintained for a long period of incubation, 
showing a marked contrast with the transient effect 
of these drugs on ‘251-EGF binding. It was mark- 
edly reduced at < 100 FM chloroquine (fig.4b). 
4. DISCUSSION 
These data demonstrate that teleocidin has a 
P 
rolonged inhibitory effect on the internalization of 
251-EGF. This cannot be explained by a reduction 
of EGF binding since the latter is a transient phe- 
nomenon. Also, the inhibition of EGF internaliza- 
tion cannot be ascribed to a slower cell growth, 
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because retinoic acid which is known to enhance the 
number of EGF receptors inhibits cell proliferation 
but not EGF internalization [ 18,191. The ability of 
teleocidin to inhibit EGF internalization may result 
from Structural and/or functional alterations of the 
cell membrane. This inhibitory effect of teleocidin 
was not detected under the usual culture conditions 
for measurement of EGF binding [ 111. To reveal the 
teleocidin effect, the addition of the lysosomal in- 
hibitor chloroquine to the incubation medium was a 
prerequisite, as were other conditions of incubation, 
i.e., temperature and time. 
Electron microscopy and marker enzyme studies 
on other types of EGF-sensitive cells have shown 
that NP 40 lysates of such cells consist of nuclei free 
from other cytoplasmic organelles, i.e., lysosomes, 
and that, following exposure to ‘251-EGF, the 
radioactivity in the lysate reflects the amount of 
ligand associated with the nucleus [ 11,151. Neverthe- 
less, it cannot be excluded that the cell lysates as 
prepared here were contaminated by other mem- 
brane structures containing EGF receptors. In the 
absence of teleocidin, 7-10s of internalized EGF 
was associated with the nucleus, a value closely 
similar to that observed in other cell-types [ 14,151; 
teleocidin reduced the amount of EGF associated 
with nuclei by 60%. This effect of teleocidin may 
simply reflect the decrease in the internalization of 
EGF. Alternatively, it may result from the inter- 
ference of teleocidin on the intracellular transport of 
EGF; indeed, lipophilic tumor-promoting agents 
such as teleocidin can easily permeate the cell 
membrane and interact with cytoplasmic or nuclear 
components [20]. 
Although the primary event involved in EGF 
action is binding to cell surface receptor, this event 
may not be sufficient for mitogenesis. A continued 
process of internalization or degradation of EGF 
and its receptor may be required to induce mito- 
genesis [21]. EGF has been shown to alter chromatin 
structure 1221, and an association of EGF with the 
nucleus has been demonstrated [ 14,151. Therefore, 
teleocidin may modulate cell proliferation as well as 
cellular functions by altering the internalization 
and nuclear accumulation of EGF and other 
growth factors. This may explain, at least in part, 
the synergistic or antagonistic effects displayed by 
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